High flow nasal cannula for continuous positive airway pressure weaning in preterm neonates: A single-centre experience

Aim High flow nasal cannula therapy (HFNC) is an emerging method of non‐invasive respiratory support therapy for premature infants. Recent evidence around its safety and efficacy for post‐extubation respiratory support is encouraging. However, its effect on long‐term respiratory outcomes is not know...

Full description

Saved in:
Bibliographic Details
Published in:Journal of paediatrics and child health 2015-02, Vol.51 (2), p.199-203
Main Authors: Sasi, Arun, Malhotra, Atul
Format: Article
Language:English
Subjects:
Babies
Catheters
Continuous Positive Airway Pressure - methods
Female
Gestational Age
Humans
Infant, Newborn
Infant, Premature
Male
neonate
non-invasive
Noninvasive Ventilation - instrumentation
Noninvasive Ventilation - methods
Oxygen Inhalation Therapy - instrumentation
Oxygen Inhalation Therapy - methods
Premature birth
respiratory
Respiratory therapy
Retrospective Studies
support
Treatment Outcome
Ventilator Weaning - methods
Weaning
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim High flow nasal cannula therapy (HFNC) is an emerging method of non‐invasive respiratory support therapy for premature infants. Recent evidence around its safety and efficacy for post‐extubation respiratory support is encouraging. However, its effect on long‐term respiratory outcomes is not known. The aim of this study is to determine the effect of HFNC on respiratory outcomes (chronic lung disease (CLD), need for home oxygen) when used to wean babies from continuous positive airway pressure (CPAP). Methods This retrospective study compared respiratory outcomes in infants born
ISSN:1034-4810
1440-1754
1440-1754
DOI:10.1111/jpc.12693